Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response -- which in ...

FUJIFILM has invested about $4 billion in building biopharmaceutical manufacturing sites and life sciences capabilities.

Mosaic Therapeutics has secured the latest pieces in its combination medicine strategy by licensing two clinical stage tumor ...

ZyVersa CEO Stephen Glover said, “ZyVersa is developing Inflammasome ASC Inhibitor IC 100 for treatment of chronic inflammatory diseases, with ...

Lyme disease, a disease transmitted when deer ticks feed on infected animals like deer and rodents, and then bite humans, impacts nearly half a million individuals in the U.S. annually.

Antibiotic-resistant illnesses, the World Health Organization says they are a global health concern, but the discovery of a ...

Piperacillin, an antibiotic in the same class as penicillin, effectively cured mice of Lyme disease at 100-times less than the effective dose of doxycycline, the current gold standard treatment. At ...

“She’s an example of this emerging face of cancer that's really quite challenging and quite alarming,” Deignan said.

In the realm of Lyme disease research, one antibiotic emerged as being highly effective for treatment of acute infection, and ...

Swiss biotech investor Xlife Sciences AG said on Wednesday its portfolio company Veraxa Biotech AG would list on U.S.

Because it’s been the greatest 100-day presidency in the history of our country.” Everything is on the table to obtain Greenland The president on Saturday also said he has “absolutely” had ...

Oncology health tech firm Flatiron Health will use Massive Bio’s patient database to identify and recruit participants for clinical trials, the Roche Group affiliate announced in an April 7 release.